BNP Paribas Financial Markets lifted its position in shares of Limoneira (NASDAQ:LMNR – Free Report) by 14.3% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 3,486 shares of the company’s stock after purchasing an additional 436 shares during the quarter. BNP Paribas Financial Markets’ holdings in Limoneira were worth $92,000 at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of LMNR. Bank of New York Mellon Corp raised its position in shares of Limoneira by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 129,738 shares of the company’s stock worth $2,700,000 after acquiring an additional 1,934 shares in the last quarter. Rhumbline Advisers lifted its position in shares of Limoneira by 7.4% during the 2nd quarter. Rhumbline Advisers now owns 22,708 shares of the company’s stock valued at $473,000 after acquiring an additional 1,565 shares during the period. American Century Companies Inc. lifted its position in shares of Limoneira by 32.9% during the 2nd quarter. American Century Companies Inc. now owns 22,198 shares of the company’s stock valued at $462,000 after acquiring an additional 5,498 shares during the period. Gabelli Funds LLC boosted its stake in Limoneira by 2.5% during the second quarter. Gabelli Funds LLC now owns 123,300 shares of the company’s stock worth $2,566,000 after acquiring an additional 3,000 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new stake in Limoneira in the third quarter worth $153,000. Institutional investors own 64.35% of the company’s stock.
Limoneira Stock Performance
Shares of LMNR opened at $25.36 on Thursday. The firm has a market capitalization of $457.80 million, a P/E ratio of 87.45 and a beta of 0.49. Limoneira has a 52 week low of $17.37 and a 52 week high of $29.22. The stock has a 50 day moving average price of $27.05 and a two-hundred day moving average price of $24.16. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.84 and a current ratio of 0.93.
Limoneira Announces Dividend
Analyst Upgrades and Downgrades
Several research analysts have issued reports on LMNR shares. Lake Street Capital reiterated a “hold” rating and issued a $25.00 price target on shares of Limoneira in a report on Tuesday, September 10th. B. Riley increased their target price on Limoneira from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, StockNews.com upgraded shares of Limoneira from a “sell” rating to a “hold” rating in a research note on Wednesday, September 11th. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Limoneira currently has an average rating of “Moderate Buy” and a consensus target price of $25.33.
Read Our Latest Research Report on Limoneira
Limoneira Company Profile
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through three divisions: Agribusiness, Rental Operations, and Real Estate Development. It grows, processes, packs, markets, and sells lemons. The company also grows avocado, oranges, and specialty citrus and other crops, including Moro blood oranges, Cara Cara oranges, Valencia oranges, Minneola tangelos, Star Ruby grapefruit, pummelos, and wine grapes.
Featured Articles
- Five stocks we like better than Limoneira
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Why is the Ex-Dividend Date Significant to Investors?
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Want to see what other hedge funds are holding LMNR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Limoneira (NASDAQ:LMNR – Free Report).
Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.